Clinical and microbiological characteristics of paediatric patients hospitalized for pneumococcal pneumonia before and after the introduction of pneumococcal conjugate vaccines
DOI:
https://doi.org/10.17843/rpmesp.2025.421.13847Keywords:
Pneumococcal Pneumonia, Pneumococcal Vaccines, Empyema, Children, LimaAbstract
The clinical and microbiological characteristics of pneumococcal pneumonia in children hospitalized in Lima were analyzed, before and after the introduction of pneumococcal conjugate vaccines (PCV). We reviewed cases that occurred
between 2006-2019, in the pre-PCV7 (2006-2008), post-PCV7 (2009-2011) and post-PCV13 (2016-2019) periods. Of 128 patients with positive cultures (92 blood and 36 pleural fluid), most were infants in the pre-PCV7 (77.1%) and post-
PCV7 (43.3%) studies, while in the post-PCV13 study they were mostly preschoolers (62%). We found an increase in complicated pneumonia cases from 14.6% to 72% and an increase in serotype 19A (6.3% to 68%). The most frequent sequence type was ST320 (31 isolates). Resistance to penicillin and ceftriaxone was low (6% and 2%, respectively), although higher in empyema (21.4% and 14.3%, respectively). Resistance to azithromycin increased from 27% to 92%. Penicillin remains the antibiotic of choice for the treatment of uncomplicated pneumococcal pneumonia in Lima.
Downloads
References
Pneumonia in children [Internet]. World Health Organization; [citado el 1 de junio de 2023]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/pneumonia.
Wahl B, Sharan A, Deloria Knoll M, Kumar R, Liu L, Chu Y, et al. National, regional, and state-level burden of streptococcus pneumoniae and haemophilus influenzae type b disease in children in India: Modelled estimates for 2000–15. The Lancet Glob Health. 2019;7(6). doi: 10.1016/s2214-109x(19)30081-6.
Ministerio de Salud. Norma Técnica de Salud que establece el esquema nacional de vacunación. NTS N°116-2016 [Internet]. MINSA; 2016 [citado el 10 de agosto de 2018]. Disponible en: https://cdn.www.gob.pe/uploads/document/file/3823311/Norma%20Técnica%20de%20Salud.pdf?v=1668009871.
Gonzales BE, Mercado EH, Pinedo-Bardales M, Hinostroza N, Campos F, Chaparro E, et al. Increase of macrolide-resistance in streptococcus pneumoniae strains after the introduction of the 13-valent pneumococcal conjugate vaccine in Lima, Peru. Front Cell Infect Microbiol. 2022;12. doi: 10.3389/fcimb.2022.866186.
Ochoa TJ, Egoavil M, Castillo ME, Reyes I, Chaparro E, Silva W, et al. Invasive pneumococcal diseases among hospitalized children in Lima, Peru. Rev Panam Salud Publica. 2010;28(2):121–7. doi: 10.1590/s1020-49892010000800008.
Luna-Muschi A, Castillo-Tokumori F, Deza MP, Mercado EH, Egoavil M, Sedano K, et al. Invasive pneumococcal disease in hospitalised children from Lima, Peru before and after introduction of the 7-valent conjugated vaccine. Epidemiol Infect. 2019;147. doi: 10.1017/s0950268819000037.
Ochoa TJ, Del Águila O, Reyes I, Chaparro E, Castillo ME, Campos F, et al. Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru. J Infect Public Health. 2023;17(1):44–50. doi: 10.1016/j.jiph.2023.10.047.
Clinical and Laboratory Standards Institute, (CLSI). (2019). Performance standards for antimicrobial susceptibility testing M100 (29th ed, Vol. 39). 9. Tran Quang K, Tran Do H, Pham Hung V, Nguyen Vu T, Tran Xuan B, Larsson M, et al. Study on the co‐infection of children with severe community‐acquired pneumonia. Pediatr Int. 2021;64(1). doi: 10.1111/ped.14853.
Fletcher MA, Schmitt H-J, Syrochkina M, Sylvester G. Pneumococcal empyema and complicated pneumonias: Global trends in incidence, prevalence, and serotype epidemiology. Eur J of Clin Microbiol Infect Dis. 2014;33(6):879–910. doi: 10.1007/s10096-014-2062-6.
Adebanjo TA, Pondo T, Yankey D, Hill HA, Gierke R, Apostol M, et al. Pneumococcal conjugate vaccine breakthrough infections: 2001–2016. Pediatrics. 2020;145(3). doi: 10.1542/peds.2019-0836.
Strachan R, Homaira N, Beggs S, Bhuiyan MU, Gilbert GL, Lambert SB, et al. Assessing the impact of the 13 valent pneumococcal vaccine on Childhood Empyema in Australia. Thorax. 2021;76(5):487–93. doi: 10.1136/thoraxjnl-2020-216032.
Gutiérrez-Tobar IF, Londoño-Ruiz JP, Mariño-Drews C, Beltrán-Higuera S, Camacho-Moreno G, Leal-Castro AL, et al. Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a Multicenter Study in Bogota, Colombia, 2008–2019. Vaccine. 2022;40(20):2875–83. doi: 10.1016/j.vaccine.2022.03.022.
Vigilancia de Laboratorio comportamiento de streptococcus pneumoniae serotipos 13 y 19A en Chile, años 2007-2015 - ISPCH [Internet]. Instituto de Salud Pública de Chile; 2016 [cited 2023 Sept 15]. Disponible en: from: https://www.ispch.cl/sites/default/files/Boletin%20S.pneumoniae%2019A%20y%203.pdf.
Gagetti P, Lo SW, Hawkins PA, Gladstone RA, Regueira M, Faccone D, et al. Population genetic structure, serotype distribution and antibiotic resistance of streptococcus pneumoniae causing invasive disease in children in Argentina. Microb Genom. 2021;7(9). doi: 10.1099/mgen.0.000636.
Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of streptococcus pneumoniae causing invasive disease in children in the post-PCV ERA: A systematic review and meta-analysis. PLoS One. 2017;12(5). doi: 10.1371/journal.pone.0177113.
Mohanty S, Feemster K, Yu KC, Watts JA, Gupta V. Trends in Streptococcus pneumoniae Antimicrobial Resistance in US Children: A Multicenter Evaluation. Open Forum Infect Dis. 2023;10(3). doi: 10.1093/ofid/ofad098.
Sandoval MM, Ruvinsky S, Palermo MC, Alconada T, Brizuela ME, Wierzbicki ER, et al. Antimicrobial resistance of streptococcus pneumoniae from invasive pneumococcal diseases in Latin American countries: A systematic review and meta-analysis. Front Public Health. 2024;12. doi: 10.3389/fpubh.2024.1337276.
Almeida SC, Lo SW, Hawkins PA, Gladstone RA, Cassiolato AP, Klugman KP, et al. Genomic surveillance of invasive streptococcus pneumoniae isolates in the period pre-PCV10 and post-PCV10 introduction in Brazil. Microb Genom. 2021;7(10). doi: 10.1099/mgen.0.000635.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Carolina A. Gomez, Brayan E. Gonzales, Roger A. Hernández , Francisco Campos, Eduardo Chaparro, Olguita Del Águila, Maria E. Castillo, Andrés Saenz, Isabel Reyes, Theresa J. Ochoa

This work is licensed under a Creative Commons Attribution 4.0 International License.